SCHEMBL29924932

SCHEMBL29924932

O=C(O)c1ccc2c(c1)sc1nc(-c3cccc(Br)c3)cn12

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.58
THRB P10828 4/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
RXFP1 Q9HBX9 2/20 0.53
NPC1 O15118 2/20 0.53
ALDH1A1 P00352 2/20 0.53
TP53 P04637 4/20 0.52
ATM Q13315 2/20 0.52
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
FLT3 P36888 1/20 0.50
POLB P06746 1/20 0.50
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29924693 0.89 MAPT (0.69) MAPTTHRBRAB9ASMN1; SMN2RXFP1
SCHEMBL24106013 0.89 MAPT (0.69) MAPTTHRBRAB9ASMN1; SMN2RXFP1
SCHEMBL29924811 0.88 MAPT (0.57) MAPTTHRBRAB9ASMN1; SMN2RXFP1
SCHEMBL24619383 0.86 RAB9A (0.58) MAPTTHRBRAB9ASMN1; SMN2RXFP1
Formic Acid SCHEMBL29924662 0.84 MAPT (0.53) MAPTTHRBRAB9ASMN1; SMN2RXFP1
SCHEMBL29925326 0.84 MAPT (0.56) MAPTTHRBRAB9ASMN1; SMN2RXFP1
SCHEMBL30537848 0.84 MAPT (0.71) MAPTTHRBRAB9ASMN1; SMN2NPC1
SCHEMBL29925028 0.84 MAPT (0.71) MAPTTHRBRAB9ASMN1; SMN2NPC1
SCHEMBL29925216 0.83 THRB (0.72) MAPTTHRBRAB9ASMN1; SMN2RXFP1
SCHEMBL7763808 0.81 MAPT (0.53) MAPTTHRBRAB9ASMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 EP disclosed
CN-116635028-A Modulators of c-MYC mRNA translation and their use in the treatment of cancer 艾尼莫生物科技公司 2023-08-22 CN disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 WO disclosed